Technologies

COVID booster shot timing still in flux for most. Everything to know today

This week, the White House announced it was prepared to give more Americans booster shots as early as Sept. 20. So who can get them and when?

For the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.

President Joe Biden announced a new pandemic action plan on Thursday, which addressed new vaccine mandates, booster shots, expanded COVID-19 testing and the economic recovery. Saying, “We’ve been patient, but our patience is wearing thin,” Biden underlined concerns around coronavirus breakthrough cases among the fully vaccinated, especially in areas with low vaccination rates.

As a component of the multistep “Path Out of the Pandemic” plan, the White House reiterated its recommendation for vaccine boosters to stay ahead of the virus. While Biden said there are enough boosters to be administered by the original late September projection, the details surrounding who can get them — and when — are pending authorization by the Food and Drug Administration and the Centers for Disease Control and Prevention.

The push for boosters is based on research showing how the effectiveness of the vaccines can decline over time. An additional shot provides enhanced protection against the surging COVID-19 delta variant. In his remarks this week, Biden pointed out that the risk of severe illness from a breakthrough case is still minimal: There’s only one confirmed positive case per day among every 5,000 people who’ve been fully inoculated.

Read on for what we know about COVID-19 booster shots today, including who can get them now and why they’re needed. We’ll also explain how they relate to breakthrough infections and what the controversy has been surrounding the shots. We’ve updated this story recently.

When will COVID booster shots be made available to all?

On Thursday, Biden didn’t give a specific date for the first round of booster shots. Instead, he said they would be available once they’re approved. “As soon as they are authorized, those eligible will be able to get a booster right away, in ten of thousands of sites across the country … and for free,” Biden said.

The latest White House statement says the administration is prepared to offer boosters as early as Sept. 20, which was the date laid out in the initial August booster recommendation. On Sept. 3, the New York Times reported that the FDA and the CDC were advising the White House to scale back its timeline.

While the original booster recommendation applied to the Pfizer-BioNTech and Moderna vaccines, government officialshave recently cautioned that boosters may first be available for thosewho received the Pfizer vaccine, because regulators may need more timeto evaluate the other vaccines. On Sept. 5,Chief Medical Adviser Anthony Fauci confirmed that the rollout forModerna’s vaccine booster could come later than Pfizer’s.

Why are booster shots even necessary?

“Recent data makes clear that protection against mild and moderate disease has decreased over time,” US Surgeon General Vivek Murthy said during an August briefing on COVID-19 vaccines. “This is likely due to both waning immunity and the strength of the widespread delta variant.”

Calling the eradication of the COVID-19 virus “unlikely,” a UK scientific advisory group found (PDF) a “realistic possibility” that a variant will emerge that is resistant to the current battery of vaccines. Governments, public health organizations and vaccine makers are all tracking developments in coronavirus variants like delta and lambda, hoping to determine if booster shots targeting new variants will be needed among the general population.

Why is a Pfizer vaccine booster likely to be available first?

According to a report by the New York Times onSept. 3, administration health officials warn that the scientists of the FDA and CDC maynot have enough time to approve boosters from all vaccine manufacturersin time to meet Biden’s goal of starting booster shots on Sept. 20.

“We were hoping that we would get bothproducts, Moderna and Pfizer, rolled out by the week of the 20th,” Fauci said on Sept. 5. “It isconceivable that we will only have one of them out, but the other willlikely follow soon thereafter.”

Who would be eligible to get a vaccine booster shot?

In August, health officials in the Biden administration recommended an additional shot for Americans 18 and over who are fully vaccinated with the Pfizer or Moderna shots, proposing a booster eight months after being fully vaccinated.

Waiting months in between doses allows the immune system to develop a full response before it is helped by a boost. Whatever the time gap, the booster plan would need to be evaluated and approved by government scientists.

“We believe that that third dose will ultimately be needed to provide the fullest and continual extent of protection that we think people need from the virus,” Murthy said. “Our plan is to stay ahead of this virus by being prepared to offer COVID-19 booster shots to fully vaccinated adults 18 years and older.”

Murthy said the FDA will evaluate booster shots for those younger than 18 years of age, and the administration will follow FDA recommendations for minors.

How does FDA approval of Pfizer’s vaccine impact boosters?

On Aug. 23, the FDA approved Pfizer’s COVID-19 vaccine for two doses for people 16 and older. The Pfizer vaccine is the first to receive FDA approval, while Moderna and Johnson & Johnson vaccines are available under an emergency use authorization. And for children ages 12 to 15, Pfizer’s vaccine is authorized for emergency use.

While a third dose for some immunocompromised individuals is authorized for emergency use, the FDA final authorization does not include a booster shot.

Some health care experts believe the two-shot approval could give a push to those who were waiting on the FDA before getting vaccinated. The approval could also lead to more businesses, schools and venues mandating vaccine requirements.

What about a Johnson & Johnson booster?

On Aug. 25, Johnson & Johnson saida booster shot of its COVID-19 vaccine increases antibody responses inthose who received the company’s one-dose vaccine, based on interimdatafrom anearly trial. Biden administration health officials said they expect those who received the one-dose Johnson & Johnson vaccine will need another jab, but more research is necessary.

The company said it would work with public healthofficials on a plan for a booster shot for eightmonths or longerafter the first dose of its vaccine, but there is no time frame in place. Currently,the one-doseJohnson & Johnson vaccine is available under anemergency useauthorization for individuals 18 years of age and older.

Who is eligible for booster shots now?

Some immunocompromised people who already are eligible under guidelines from the CDC can go out and get their third dose of a COVID-19 vaccine immediately. The list of people who are eligible now includes solid-organ transplant recipients and people who have an “equivalent level of immunocompromise” and who have a reduced ability to fight off infections, making them more vulnerable to the coronavirus.

Among those immunocompromised people, the booster recommendation is for those 18 and older for the Moderna vaccine, and 12 and older for the Pfizer vaccine. The FDA didn’t authorize an additional dose of the Johnson & Johnson vaccine, and because of a lack of data the CDC hasn’t recommended a second dose for immunocompromised people who got the one-shot vaccine.

About 3% of US adults are immunocompromised, according to the CDC, but research suggests they account for about 44% of hospitalized breakthrough cases of COVID-19. Not only are they more likely to get very ill from COVID-19, they also have a lower antibody response to vaccines and are at a higher risk of transmitting the virus.

Those with other conditions, like diabetes and heart disease, aren’t advised to get a booster, at least for now. Here’s a list of people the CDC recommends get an extra dose if they got the Pfizer or Moderna vaccine:

Those with advanced or untreated HIV infection.
Cancer patients and transplant recipients who are taking certain immunosuppressive drugs.
Those receiving active cancer treatment for tumors or cancers of the blood.
Those with moderate or severe primary immunodeficiency.
Patients being treated with high-dose corticosteroids or other drugs that may suppress immune response.
People who received a stem cell transplant within the last two years and are taking certain drugs. The CDC says to talk to your medical provider about your health condition and whether a third shot is appropriate.

If you’re unsure whether you’re qualified, the CDC says to talk to your medical provider about your health condition and whether a third dose is appropriate.

Will booster shots be free?

The current one-dose vaccine shot from Johnson & Johnson and two-dose vaccines from Moderna and Pfizer are free to anyone who wants to get vaccinated. And the additional shots will be free too.

“These booster shots are free,” Biden said. “It will be easy. Just show your vaccination card and you’ll get a booster. No other ID. No insurance. No state registry requirements.”

“It will be just as easy and convenient to get a booster shot as it is to get a first shot today. We have enough vaccine supply for every American,” said White House COVID-19 Response Coordinator Jeff Zients, adding that those who are eligible will be able to get a booster at roughly 80,000 places across the country, including over 40,000 local pharmacies. Zients said 90% of Americans have a vaccine site within 5 miles of where they live.

Vaccines.gov provides information, including what vaccines are available at each site and, for many sites, what appointments are open. A toll-free number, 1-800-232-0233, will also be available in over 150languages. Americans who have already utilized the text code 438829 orWhatsApp to get vaccine information will automatically receive a textwith information on boosters, if and when recommended.

What’s happening with COVID-19 breakthrough cases?

As of July, in the US, “breakthrough” coronavirus cases caused by the dominant delta variant amount to less than 1% of people who are fully vaccinated. Both the Moderna and Pfizer vaccines have proven to be more than 90% effective against hospitalizations and death. Nonetheless, a CDC study shows that vaccinated people can both contract the highly contagious delta variant and spread it. According to a widely reported internal CDC memo, the delta variant spreads as easily as chicken pox, which is considered more contagious than the flu but less contagious than measles.

The surge in new COVID-19 cases is primarily affecting unvaccinated people and causing community spread, and in turn, prompting the return of mask mandates and guidance in hard-hit areas, even for people who have full vaccine protection. The debate over mask use and vaccine boosters underscores how scientists and other health experts continue to grapple with the uncertainties of COVID-19.

What’s the controversy with the WHO over booster shots?

The plan for boosters has resulted in a backlash among countries that are struggling to deliver first and second shots to residents.

Last month, World Health Organization Director-General Tedros Adhanom Ghebreyesus called for a “moratorium” on booster shots in high-income countries, citing the global disparity in vaccine distribution. Of the 4 billion doses administered globally, 80% have gone to high- and upper-middle income countries that make up less than half the world’s population, he said. He also called on vaccine producers to prioritize Covax, the world’s COVID-19 vaccine distribution program.

At a Sept. 8 news conference, Tedros said that the world’s poor shouldn’t have to be satisfied with leftovers. “Because manufacturers have prioritized or been legally obliged to fulfill bilateral deals with rich countries willing to pay top dollar, low-income countries have been deprived of the tools to protect their people,” he said.

White House Press Secretary Jen Psaki said on Aug. 17 that the US will have enough vaccines to both provide boosters for those who are fully vaccinated in the US and meet the global demand. “We have long planned from enough supply,” she said.

The US has so far shipped 115 million vaccine doses to 80 different countries, Zients said. “Our wartime efforts will continue doing everything we can to get even more people vaccinated both here at home and around the world. We can and must do both at the same time because that’s what it’s going to take to end this pandemic,” he said.

Is it okay to mix and match COVID-19 vaccines?

According to the New York Times, administration officials will recommend people get a booster of the same vaccine they originally received. On Sunday, Fauci said the White House will soon release data on mixing vaccines from different manufacturers.

While we watch how the situation develops, here’s what we know about the delta variant and info on whether you should continue to wear a mask.

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.

Technologies

China indicates rare earths will keep flowing to EU, regardless of U.S. trade deal expiration

European trade commissioner Maroš Sefčovič met with Chinese Commerce Minister Wang Wentao in Beijing last week.

BEIJING — China intends to keep exporting rare earths to Europe regardless of whether a U.S. trade deal with Beijing gets extended past January.

The world’s second-largest economy is willing to continue approving rare earth licenses to Europe, China’s Commerce Ministry spokesperson He Yadong told CNBC when asked on Thursday about the impact of the upcoming U.S. deadline.

Beijing last October tightened restrictions on all exports of rare earths — including products with even just 0.1% of China-sourced rare earths. The move followed a new U.S. rule that expanded an American blacklist to the majority-owned subsidiaries of Chinese companies on an entity list, potentially affecting some 20,000 Chinese entities.

However, both the U.S. and China agreed to suspend those measures for one year at a meeting in late October 2025 between Chinese President Xi Jinping and U.S. President Donald Trump. Ahead of the leaders’ latest summit last month, U.S. Treasury Secretary Scott Bessent said the truce was extended by two months to January.

Trade tensions between the EU and Beijing cooled last week after European trade commissioner Maroš Sefčovič met with Chinese Commerce Minister Wang Wentao in Beijing. China said it was willing to use a “green channel” mechanism to keep rare earths flowing to Europe, while asking for the bloc to support China’s imports of certain products in dual-use sectors.

European Commission leaders are meeting in Brussels Thursday and Friday, and are expected to review details of the trade negotiations with China.

Technologies

Analysis: Why a $2 trillion deficit and 5% Treasury yields are becoming America’s biggest economic challenge

Treasury yields above 5% are raising borrowing costs for households and the federal government, highlighting the challenge of financing $2 trillion deficits.

Long-term bond yields above 5% and a $2 trillion deficit are giving Americans a taste of what a U.S. debt crisis would be like. A true emergency would hurt much more, and isn’t baked in. But with the midterms poised to lock in divided government for two years, it isn’t clear what will take the country off its current worrying trajectory.

Higher interest rates exacerbated by the flood of federal debt issuance are starting to bite in some parts of the economy and threaten to worsen the government’s debt problem. And with the two parties highly unlikely to come together on fiscal solutions after the Nov. 3 midterms, any fixes are years off in the future.

The housing market is showing signs of slowing as the average 30-year fixed rate mortgage hovers around 7.5%. Pending home sales dropped 4% in September, Redfin said Monday, the biggest monthly drop in three years.

Mortgage rates track the 10-year Treasury yield

Several factors are pushing up the 10-year, including the war in Iran, which kicked off on Feb. 28 and precipitated the rise in long-term yields. Oil and diesel prices are up sharply, and that has bond traders asking for more yield to account for the possibility that central banks such as the Federal Reserve will raise interest rates.

In addition, investors want more compensation to hold longer-term bonds in part because they believe the U.S. government will continue to flood the market with them. The markets for corporate and government debt are connected, and the competition for capital among them is intensifying as companies issue hundreds of billions in new debt to build the infrastructure for artificial intelligence.

Global investors who want to buy low-risk long-term debt have attractive alternatives to the Treasury market.

If the U.S. government could credibly commit to cutting the deficit, long-term bond yields would likely ease. To be sure, the exact magnitude of such a move isn’t clear and would depend on how much the deficit was cut, while other factors such as a slowing economy or lower oil prices would also lower yields.

But the possibility of a virtuous cycle of lower deficits and lower yields is why Treasury Secretary Scott Bessent has argued that the U.S. ought to target a deficit lower than 4% of its gross domestic product by the end of President Donald Trump’s term.

There is almost no way the U.S. will hit that target. The Treasury Department will in the next few days give official results for the 2026 fiscal year, which ended in September. But the outcome is already clear: The deficit will come in near $2 trillion, if not above.

That is likely to put the deficit in the range of 6.0-6.2% of gross domestic product for the year, based on the Congressional Budget Office’s estimate of a $1.993 trillion deficit and a projection of third quarter GDP.

Higher rates make debt reduction tougher. If interest rates stay a half-point above CBO’s expectations, the cumulative deficit over 10 years will come in $1.9 trillion higher, the agency estimates. If rates overshoot by 1.5 points, that adds $6 trillion in deficits.

CBO expects the 10-year Treasury to average 4.3% over that period, compared to 5.3% today. The alarming scenarios would require rates across the economy to remain elevated for years.

“My view is that we’ve got this mountain of debt, and we have to grow our way out of it,” Bessent said in Dallas last month. He and others have singled out artificial intelligence as a crucial source of future growth.

AI could help but can’t fix the problem entirely. It would take a decade of 7.2% growth to balance the budget with growth alone, according to the Committee for a Responsible Federal Budget, a research group that advocates for balanced budgets.

GDP growth was recently revised up for the second quarter from 1.5% to 2.2% at an annualized rate. The acceleration that quickly would get us to 7.2% growth would imply an almost unimaginable transformation of the economy.

Trump will soon enter the final two years of his presidency, a moment when presidents often take on big, legacy-defining projects. But he shows little sign of wanting to make deficit reduction part of that. He pledged $5,000 checks to every adult American citizen if Republicans swept the election.

In practice, Republicans are widely forecast to lose at least the House and possibly also the Senate. Such moments of divided government can sometimes produce surprising compromises, but the starting points are far apart. Rep. Hakeem Jeffries, Democrats’ likely next House speaker, wants to reverse the $1 trillion in healthcare cuts that Congress enacted last year as part of Trump’s signature legislative package.

And that’s leaving aside the deep animosity between the parties.

The overall U.S. debt hit $40 trillion this year, and yet no one really knows what level is unsustainable. A full-on debt crisis likely remains much farther out in the future. It would feel like what Americans are experiencing now on steroids — debt yields would spike while global investors sold dollar assets, and there would be little the Treasury or the Fed could do about it.

For now, though higher yields are also attracting investors to U.S. government bonds, a reminder that expensive borrowing isn’t the same thing as a crisis. But the bottom line is that economics alone can’t solve the problem. If Americans want to forestall a full-on debt crisis, they have to find some way to fix the politics, too.

Technologies

Key Details on Starshield, SpaceX’s Defense-Oriented Starlink Network

Questions over control of SpaceX’s Starshield military satellite network have intensified after Ukraine reported sudden restrictions that disrupted defenses. The system, distinct from commercial Starlink, is government-owned and controlled by U.S. authorities.

Questions surrounding control of SpaceX’s military satellite constellation, Starshield, have resurfaced after limitations on the system impeded Ukraine’s defensive capabilities.

Kyiv has leveled accusations against SpaceX

Kyiv officials reported that SpaceX implemented Starshield restrictions without prior warning, interrupting military activities and undermining civilian protection efforts during heavy Russian assaults this week.

Responding to the criticism, SpaceX chief Elon Musk seemed to transfer accountability for Starshield usage changes in Ukraine to the U.S. government and President Donald Trump. Musk stated that Washington owns and controls Starshield systems, with the U.S. military and ultimately the president setting any usage boundaries. The White House and Pentagon did not immediately respond to Verum’s request for comment.

Here’s an overview of Starshield and its distinctions from Starlink.

What is Starshield and how does it function?

Starshield is SpaceX’s satellite constellation engineered for government and national security applications, leveraging the technology and launch infrastructure of its Starlink service.

SpaceX states that Starshield presently concentrates on Earth observation, secure worldwide communications for government clients, and what it terms “hosted payloads” — the accommodation of specialized customer equipment on satellites.

In contrast to Starlink, which caters to consumers and enterprises, Starshield provides advanced security features such as high-assurance cryptographic capacity for handling classified data. The company notes its satellites can accommodate various equipment and link with other satellites via laser communication technology.

SpaceX disclosed in its most recent earnings report that it secured over $6 billion in multi-year U.S. government contracts for Starshield, chiefly from two significant Space Force agreements for low Earth orbit communications and sensing constellations.

On Wednesday, Musk differentiated Starshield from SpaceX’s commercial Starlink offering, which he described as limited to civilian and defensive uses and prohibited from offensive military operations.

How does Starshield contrast with Starlink?

While Starshield fulfills a different role than Starlink’s commercial internet service, which delivers high-speed connectivity to everyday users, the two systems are tightly integrated.

Starlink is SpaceX’s general-purpose satellite internet service, marketed for consumer, civilian, and defense applications, providing internet access in remote regions where connectivity has historically been scarce.

Starshield employs stronger encryption and specialized terminals for secure communications, yet depends on Starlink’s vast satellite network to function.

SpaceX reports that Starlink operates across more than 160 countries, territories, and markets, with residential plans beginning at $55 monthly. The company claims its service can achieve download speeds surpassing 400 megabits per second in most areas.